TMCnet News
Global Breast Cancer Therapeutics Market Analysis 2016 - Forecast to 2022 - Research and MarketsResearch and Markets has announced the addition of the "Global Breast Cancer Therapeutics Market Analysis 2016 - Forecast to 2022" report to their offering. This report analyzes the global markets for "Breast Cancer Therapeutics". The market assessment is performed through standard and the tailored research methodology approach. Annual estimations and forecasts are provided from the year 2013 to 2022 for each given segment and sub segments. Market data derived from the authenticated and reliable sources is subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends. Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, and other activities. This report provides:
1 Introduction 2 Executive Summary 3 Market Analysis 4 Porters Five Force Analysis 4.1 Bargaining power of suppliers 4.2 Bargaining power of buyers 4.3 Threat of substitutes 4.4 Threat of new entrants 4.5 Competitive rivalry 5 Breast Cancer Therapeutics Market by Drug Class 5.1 Introduction 5.2 Hormone Receptor 5.3 Mitotic Inhibitors 5.4 HER2 Inhibitors 5.5 Anti-metabolites 5.6 Aromatase Inhibitors 6 Geographical Segmentation 7 Vendor Landscaping 7.1 Agreements, Partnerships, Collaborations and Joint Ventures 7.2 Acquisitions & Mergers 7.3 New Product Launch 7.4 Expansions 7.5 Other Key Strategies 8 Company Profiles
For more information about this report visit http://www.researchandmarkets.com/research/d79447/global_breast Related Topics: Women's Health, Breast Cancer Drugs
View source version on businesswire.com: http://www.businesswire.com/news/home/20160920005931/en/ |
